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Telomere dysfunction has previously been linked to metabolic disorders. In this issue of Cell
Reports, Martı´nez et al. (2013) and Yeung et al. (2013) now extend this link, demonstrating that
deletion of the telomere binding protein RAP1 leads to obesity and insulin resistance.Changes in telomeres, the repetitive
TTAGGG sequences at chromosome
ends, have been implicated in aging.
Mechanistically, it is believed that telo-
mere shortening-induced activation of
the DNA damage response leads to
depletion of stem and progenitor cells
and subsequent regenerative impairment.
Recently, it was also demonstrated
that the telomere shortening-associated
DNA damage response represses PGC-
1a and PGC-1b, which are important
regulators of mitochondrial biogenesis/
function and diverse metabolic pro-
cesses. (Sahin et al., 2011). Such findings
suggested that telomere dysfunction may
contribute to age-related disease and
decline through metabolic changes.
Two manuscripts published in this
issue of Cell Reports further link telo-
meres to PGC deregulation and meta-
bolism, albeit with a surprising twist.
Studying the telomere binding protein
RAP1 (Repressor activator protein 1),
both papers report that RAP1 deficiency
leads to PGC-1a repression in the
absence of any overt DNA damage
(Martı´nez et al., 2013; Yeung et al.,
2013). Initially identified as a general tran-
scriptional factor in S. cerevisiae (budding
yeast) (Shore and Nasmyth, 1987), RAP1
was subsequently found to be enriched
at telomeres, where it is involved in telo-
mere-length regulation, telomere stability,
and silencing of subtelomeric genes
(Hardy et al., 1992; Lustig et al., 1990).
In its nontelomeric role, RAP1 controls
metabolism in budding yeast through
regulation of glycolytic enzymes and ribo-
somal genes (Shore, 1994). Although
RAP1 functions have been well describedCin yeast, the role of RAP1 in mammalian
telomere biology and metabolism is
beginning to emerge through studies in
knockout mice. RAP1 knockout mice
were reported to be viable, and initial
studies demonstrated that, in contrast to
S. cerevisiae RAP1, mouse RAP1 is not
required for inhibition of nonhomologous
end-joining in mouse embryonic fibro-
blasts, whereas it is required for sup-
pression of homology-directed repair
(Sfeir et al., 2010; Martı´nez et al., 2010).
Martı´nez et al. also observed significant
transcriptional changes of metabolic and
other genes in RAP1-deficient cells,
indicating a transcriptional function for
mammalian RAP1 (Martı´nez et al., 2010).
Chromatin immunoprecipitation se-
quencing analysis revealed that RAP1
binds throughout chromosome arms
and suggested a link between RAP1 and
metabolic regulation, cell adhesion, and
cancer (Martı´nez et al., 2010). Martı´nez
et al. (2013) and Yeung et al. (2013) now
provide additional insight into how RAP1
is linked to the development of obesity
and insulin resistance. Building on initial
observations that RAP1-deficient mice
gain more weight, these studies provide
evidence that RAP1 deficiency leads to
age-dependent obesity and insulin resis-
tance that is more accentuated in fe-
males. Although the mechanism by which
RAP1 deficiency leads to obesity and in-
sulin resistance remains to be fully estab-
lished (RAP1mutants had food intake and
energy expenditure similar to that of wild-
type mice), gene-expression analysis of
liver and white-fat tissues in young, unaf-
fected RAP1-deficient mice points to the
importance of Ppara and Pgc-1a regula-ell Reports 3, June 27, 2013 ª2013 The Authotion, genes previously implicated in
insulin resistance and diabetes. Indeed,
Ppara- and Pgc-1a-deficient mice de-
velop age-dependent obesity that is
more pronounced in female mice, a
sexual dimorphism also seen in PPARa
gene regulation (Leone et al., 1999,
Costet et al., 1998). In liver tissues,
Martı´nez et al. (2013) demonstrate that
RAP1 binds to both the Ppara and
Pgc-1a regulatory regions and positively
modulates their expression. An open
question is whether the observed PGC-
1a changes in RAP1mutants lead tomito-
chondrial changes. Additional studies
examining mitochondrial biogenesis and
function may help unravel the mechanism
underlying the RAP1 phenotype.
Another question is how mammalian
RAP1 affects transcription, as mamma-
lian RAP1 has only a single Myb-like
DNA binding domain, in contrast to two
domains in yeast that seem to be required
for direct DNA binding. Instead, RAP1 is
recruited to telomeres by TRF2 binding
in mammalian cells. Using a separation-
of-function mutant of TRF2, Yeung et al.
(2013) demonstrate that transcriptional
changes are largely independent of
TRF2 binding. RAP1 may thus directly
bind DNA in vivo, or RAP1 may have an
unidentified DNA binding partner.
Lastly, these two studies provide a
framework for studying the link between
RAP1 and aging. Although telomere
shortening and the associated DNA
damage response have been studied
during normal aging, the role of shelterin
components in this process is less ob-
vious. It is unclear whether RAP1 expres-
sion and/or RAP1 promoter occupancyrs 1757Open access under CC BY-NC-ND license.
changes during aging. One mechanism
for how RAP1 could be affected during
aging may be through the NF-kB com-
plex, which positively regulates RAP1
expression (Teo et al., 2010). Aging is
associated with increased inflammation
and NF-kB activation, which might
conceivably lead to altered RAP1 expres-
sion or function. RAP1 levels may also be
modulated by changes in telomere length
and/or structure and the DNA damage
response pathway. In this case, changes
at telomeres could influence overall
RAP1 levels, thereby altering RAP1 pro-
moter occupancy. Alternatively, activa-
tion of the DNA damage response
pathway could modulate RAP1 expres-
sion levels. Future studies will resolve1758 Cell Reports 3, June 27, 2013 ª2013 Thand test these possibilities, giving further
insight into the diverse roles of telomere
binding proteins.
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